NEW YORK, Jan. 10, 2019 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been
filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to
request that the court appoint you as lead plaintiff.
XPO Logistics, Inc. (NYSE: XPO)
Class Period: February 26, 2014 to December 12, 2018
Lead Plaintiff Deadline: February 12, 2019
During the class period, XPO Logistics, Inc. allegedly made materially false and/or misleading statements and/or
failed to disclose that: (i) XPO’s highly touted aggressive M&A strategy had yielded only minimal returns to the Company; (ii)
XPO was utilizing improper accounting practices to mask its true financial condition, including, inter alia, under-reporting of bad
debts and aggressive amortization assumptions; and (iii) as a result, the Company’s public statements were materially false and
misleading at all relevant times.
Get additional information about the XPO lawsuit: http://www.kleinstocklaw.com/pslra-1/xpo-logistics-inc-loss-submission-form?wire=3
Teladoc Health, Inc. (NYSE: TDOC)
Class Period: March 3, 2016 to December 5, 2018
Lead Plaintiff Deadline: February 11, 2019
The lawsuit alleges Teladoc Health, Inc. made materially false and/or misleading statements and/or failed to
disclose during the class period that: (i) Executive Vice President and Chief Operating Officer Mark Hirschhorn was engaged in an
inappropriate sexual relationship with a subordinate; (ii) Hirschhorn and this subordinate engaged in insider trading to provide
themselves with undue benefits; (iii) Hirschhorn caused the subordinate to receive promotions for which she was unqualified,
thereby negatively impacting the Company’s operations; (iv) the Company’s enforcement of its own purported employment and trading
policies were inadequate to prevent the foregoing conduct; and (v) as a result, the Company’s public statements were materially
false and misleading at all relevant times.
Get additional information about the TDOC lawsuit: http://www.kleinstocklaw.com/pslra-1/teladoc-health-inc-loss-submission-form?wire=3
Dentsply Sirona, Inc. (NASDAQ: XRAY)
Class Period: (i) all persons who purchased the common stock of Dentsply Sirona, Inc. (NASDAQ: XRAY) between February 20, 2014 and
August 7, 2018; (ii) all Dentsply International Inc. shareholders who held shares as of the record date of December 2, 2015 and
were entitled to vote with respect to the Acquisition at the January 11, 2016 special meeting of Dentsply International Inc.
shareholders; and (iii) all persons who purchased or otherwise acquired the common stock of Dentsply International in exchange for
their shares of common stock of Sirona in connection with the Acquisition
Lead Plaintiff Deadline: February 9, 2019
According to the complaint, during the Class Period, Defendants attributed the Company’s financial performance
to the Company’s “innovation,” “operational improvement efforts,” “new products,” and “continued investments in sales and
marketing” and told investors that these factors helped the Company succeed despite the “highly competitive” market for its
products. In reality, the Company’s financial results had been buoyed by an anticompetitive scheme among the Company’s three
primary distributors that suppressed competition in the dental supply market and artificially inflated the price of dental supplies
sold by Dentsply. Further, Defendants concealed that an exclusive distribution arrangement that Sirona had with one of its
distributors, Patterson Companies, Inc. (“Patterson”), required Patterson to regularly make large minimum purchases regardless of
demand and, as a result, by 2015, Patterson had been supplied with so much excess inventory that it could not be sold. This
channel-stuffing rendered the Company’s reported sales, financial results and guidance materially false and misleading. In
addition, the Company represented that it reported its financial statements, including its goodwill, in accordance with generally
accepted accounting principles, or GAAP. In fact, the Company’s reported goodwill was artificially inflated and not reported in
accordance with GAAP because it did not reflect the financial impact of the anticompetitive scheme.
Get additional information about the XRAY lawsuit: http://www.kleinstocklaw.com/pslra-1/dentsply-sirona-inc-loss-submission-form?wire=3
Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or
obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact J.
Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud
throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com
